01 1SI Group
01 1IBUPROFEN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-11
Pay. Date : 2013-01-09
DMF Number : 5381
Submission : 1984-06-01
Status : Active
Type : II
20
Si Group, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBUPROFEN, with a corresponding US DMF Number 5381.
Remarkably, this DMF maintains an Active status since its submission on June 01, 1984, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 11, 2012, and payment made on January 09, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
